| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Universite Henri-Poincare, France
2 Department of Medicine, Meakins-Christie Laboratories-McGill Univeristy, Montreal, Quebec, Canada
* To whom correspondence should be addressed. E-mail: laura.pini{at}mcgill.ca.
Administration of bleomycin (BM) produces inflammation and fibrosis of the lung in humans and experimental animals. The molecular defects by which BM induces these pathologic effects have not been studied in detail. We studied the expression of Smad family proteins, key molecules involved in mediating TGF-
signaling from the cell membrane to nucleus, during the early and late phases of BM-induced fibrogenesis. Pulmonary fibrosis was induced in male Sprague-Dawley rats by a single intratracheal injection (1.5 U) of BM. Control rats received saline. Rats were sacrificed at 3, 5, 7, 14 and 28 days after BM, cytosolic and nuclear proteins extracted and isolated from lung
tissues, and Smad proteins probed with specific antibodies. In BM exposed lung tissue, as compared to control, Smad3 decreased persistently in the cytosol, and increased
transiently in the nucleus. There was a persistent increase in phosphorylation and nuclear accumulation of Smad2/3. Smad4 was increased transiently in both the cytosol and
nucleus. A significant and progressive decrease in the expression of Smad7, the endogenous inhibitor of TGF-/Smad signaling, was observed after BM instillation.
Collectively, our results indicate that an imbalance between agonistic Smads2-4 and antagonistic Smad7 may result in the unchecked activation of an autocrine TGF- loop, which contributes to the pathogenesis of bleomycin-induced pulmonary fibrosis.
This article has been cited by other articles:
|
|
 |
|
  C. Dasgupta, R. Sakurai, Y. Wang, P. Guo, N. Ambalavanan, J. S. Torday, and V. K. Rehan Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1031 - L1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T J Williams and J W Wilson Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation Thorax, March 1, 2008; 63(3): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Guo, J. C.K. Leung, M. F. Lam, L. Y.Y. Chan, A. W.L. Tsang, H. Y. Lan, and K. N. Lai Smad7 Transgene Attenuates Peritoneal Fibrosis in Uremic Rats Treated with Peritoneal Dialysis J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2689 - 2703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Higashiyama, D. Yoshimoto, Y. Okamoto, H. Kikkawa, S. Asano, and M. Kinoshita Receptor-activated Smad localisation in Bleomycin-induced pulmonary fibrosis J. Clin. Pathol., March 1, 2007; 60(3): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Gonzalez, F. Le Bellego, and M. S. Ludwig Imbalance of Receptor-Regulated and Inhibitory Smads in Lung Fibroblasts from Bleomycin-Exposed Rats Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 206 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maeda, V. Dave, and J. A. Whitsett Transcriptional Control of Lung Morphogenesis Physiol Rev, January 1, 2007; 87(1): 219 - 244. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
